Abstract

The B cell response to influenza infection of the respiratory tract contributes to viral clearance and establishes profound resistance to reinfection by related viruses. Numerous studies have measured virus-specific antibody-secreting cell (ASC) frequencies in different anatomical compartments after influenza infection and provided a general picture of the kinetics of ASC formation and dispersion. However, the dynamics of ASC populations are difficult to determine experimentally and have received little attention. Here, we applied mathematical modeling to investigate the dynamics of ASC growth, death, and migration over the 2-week period following primary influenza infection in mice. Experimental data for model fitting came from high frequency measurements of virus-specific IgM, IgG, and IgA ASCs in the mediastinal lymph node (MLN), spleen, and lung. Model construction was based on a set of assumptions about ASC gain and loss from the sampled sites, and also on the directionality of ASC trafficking pathways. Most notably, modeling results suggest that differences in ASC fate and trafficking patterns reflect the site of formation and the expressed antibody class. Essentially all early IgA ASCs in the MLN migrated to spleen or lung, whereas cell death was likely the major reason for IgM and IgG ASC loss from the MLN. In contrast, the spleen contributed most of the IgM and IgG ASCs that migrated to the lung, but essentially none of the IgA ASCs. This finding points to a critical role for regional lymph nodes such as the MLN in the rapid generation of IgA ASCs that seed the lung. Results for the MLN also suggest that ASC death is a significant early feature of the B cell response. Overall, our analysis is consistent with accepted concepts in many regards, but it also indicates novel features of the B cell response to influenza that warrant further investigation.

Highlights

  • The antibody (Ab) response against influenza infection involves activation and progressive differentiation of virus-specific B cells into Ab-secreting cells (ASCs)

  • Cell suspensions prepared from mediastinal lymph node (MLN), spleen, and lung on days 0 to 14 after infection were analyzed by ELISpot assay to determine virus-specific ASC numbers

  • Model 1 outperformed Model 2 for each of the IgM, IgG, and IgA ASC populations, indicating that the increase in ASC populations can be well estimated without introducing the non-parametric form of the synergistic stimulation effects as in Model 2

Read more

Summary

Introduction

The antibody (Ab) response against influenza infection involves activation and progressive differentiation of virus-specific B cells into Ab-secreting cells (ASCs). A similar process occurs during intramuscular influenza vaccination In both cases, Ab-mediated immunity develops after influenza-specific B cells produce high affinity Abs, most importantly against the haemagglutinin (HA) protein responsible for viral binding to target respiratory epithelial cells. B cells activated by influenza infection or vaccination may develop into ASCs secreting the IgM Ab class, or may undergo class switching during the differentiation process and form IgG or IgA ASCs. The Ab class reflects functional capabilities of the immunoglobulin molecule, such as complement activation, Fc receptor binding, and transcytosis of epithelial cells at mucosal surfaces. In sites of ASC formation, a peak of IgM ASCs typically precedes increasing numbers of IgG and IgA ASCs. Influenza-specific ASC numbers in the regional lymph nodes and spleen gradually wane after clearance of infectious virus, but in the course of the response ASCs traffic to the respiratory tract and bone marrow and establish long-lasting populations. Serum IgM levels peak at 8–10 days and gradually decline, reflecting the

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.